Výsledky vyhledávání - "Ariel F Gonzalez"

Akademický článek

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial

Autor: Dagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, Hector J Nunez, Ariel F Gonzalez, Lorena Gonzalez-Sepulveda, Sona Rivas-Tumanyan, Hetanshi Naik, Gualberto Ruaño, Stuart A Scott, Jorge Duconge

Publikováno v: BMJ Open, Vol 10, Iss 8 (2020)

Introduction Minority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers of CYP2C19 variants has been reported in patients with either coronary artery disease (CAD

Externí odkaz: https://doaj.org/article/a25cc988e2f8412da95b6ee78b586984

Zobrazit plný text záznamu

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial

Autor: Stuart A. Scott, Frances Marin-Maldonado, Dagmar F. Hernandez-Suarez, Gualberto Ruaño, Hetanshi Naik, Sona Rivas-Tumanyan, Kyle Melin, Jorge Duconge, Lorena González-Sepúlveda, Hector J Nunez, Ariel F. Gonzalez

Publikováno v: BMJ Open
BMJ Open, Vol 10, Iss 8 (2020)

IntroductionMinority populations in the USA are disproportionately affected by cardiovascular conditions. Reduced responsiveness to clopidogrel among carriers ofCYP2C19variants has been reported in patients with either coronary artery disease (CAD) o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f438a059bbb369bddf17a988192d6829
https://pubmed.ncbi.nlm.nih.gov/32764090

Zobrazit plný text záznamu

USE OF MIDODRINE TO DECREASE HOSPITALIZATION LENGTH IN END-STAGE HEART FAILURE

Autor: Marcel Mesa Pabon, Ariel F. Gonzalez, Hilton Franqui-Rivera

Publikováno v: Journal of the American College of Cardiology. 75:2583

Heart failure (HF) has been termed a global public health burden, with a prevalence of 23 million cases worldwide. Approximately 5% of patients with heart failure progress to end-stage disease refractory to medical therapy. Often these patients do no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5766a5d804c8dfa0a28b5c9cc61406bf
https://doi.org/10.1016/s0735-1097(20)33210-1

Zobrazit plný text záznamu

A YOUNG PATIENT WITH RECURRENT ACUTE ST-ELEVATION MYOCARDIAL INFARCTION AND APICAL THROMBUS CAUSED BY ANTIPHOSPHOLIPID SYNDROME

Autor: Marcel Mesa Pabon, Juan E Carrillo Navas, Hilton Franqui-Rivera, Bayoan M. Ramos Parra, Ariel F. Gonzalez, Melissa Ruiz Rodriguez

Publikováno v: Journal of the American College of Cardiology. 73:2391

Antiphospholipid syndrome (APS) is a systemic autoimmune disease of an acquired hypercoagulable state that causes arterial and venous thrombosis. APS is extremely rare in young individuals, and even more so to present with myocardial infarction. A 26

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::933c2bb7954efd4bc21ddc9229e49745
https://doi.org/10.1016/s0735-1097(19)32997-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání